imdevimab - Search results - Wiki Imdevimab
There is a page named "Imdevimab" on Wikipedia
Casirivimab/imdevimab, sold under the brand name REGEN‑COV among others, is a combination medicine used for the treatment and prevention of COVID‑19.... |
monoclonal antibody therapies bamlanivimab/etesevimab and casirivimab/imdevimab were given emergency use authorizations by the US Food and Drug Administration... |
"Casirivimab injection, solution, concentrate Imdevimab injection, solution, concentrate REGEN-COV – casirivimab and imdevimab kit". DailyMed. Archived from the original... |
"Casirivimab injection, solution, concentrate Imdevimab injection, solution, concentrate REGEN-COV- casirivimab and imdevimab kit". DailyMed. Retrieved 18 March... |
Bebtelovimab§ Casirivimab† (+imdevimab) Cilgavimab† (+tixagevimab)† Diridavumab§ Etesevimab† Exbivirumab§ Foravirumab§ Imdevimab† (+casirivimab) Libivirumab§... |
treatments – bamlanivimab/etesevimab (administered together) and casirivimab/imdevimab – to limit their use to only when the recipients are likely to have been... |
plasma in COVID-19 in December 2021. Monoclonal antibodies (casirivimab/imdevimab) were developed for the treatment of COVID-19. On June 7, 2021, the FDA... |
2021. "Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19". Roche (Press release)... |
Bamlanivimab/etesevimab Bamlanivimab Etesevimab Bebtelovimab Casirivimab/imdevimab Regdanvimab Sarilumab Sotrovimab Tixagevimab/cilgavimab Tocilizumab Small... |
on its own. At high enough concentrations, casirivimab, etesevimab and imdevimab appear to still be effective. A preprint study suggests that sotrovimab... |
(INN) carzelesin (INN) carzenide (INN) Casgevy casimersen casirivimab and imdevimab Casodex casokefamide (INN) casopitant (USAN, INN) caspofungin (INN) Casporyn... |
monoclonal antibody therapies bamlanivimab/etesevimab and casirivimab/imdevimab were found to reduce the number of hospitalizations, emergency room visits... |
Ansuvimab J06BD05 Sotrovimab J06BD06 Regdanvimab J06BD07 Casirivimab and imdevimab J06BD08 Nirsevimab Immune sera and immunoglobulins for veterinary use... |
effect on BA.2, which was "almost completely resistant" to casirivimab and imdevimab, and 35 times more resistant to sotrovimab than the BA.1 subvariant.[citation... |
rolling reviews of data on the use of the monoclonal antibodies casirivimab/imdevimab, bamlanivimab/etesevimab, and bamlanivimab for the treatment of COVID-19... |